|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 07:00 09-Apr-2013 | SCLP | Appointment of Non-Executive Director | RNS | +5.52% |
| 07:00 14-Mar-2013 | SCLP | Re: The Journal of Clinical Investigation Paper | RNS | +0.88% |
| 14:00 27-Feb-2013 | SCLP | Directorate Change | RNS | +1.52% |
| 07:00 06-Feb-2013 | SCLP | ImmunoBody patent approved for grant in Japan | RNS | -2.10% |
| 07:00 31-Jan-2013 | SCLP | Half Yearly Report | RNS | -0.79% |
| 07:00 29-Jan-2013 | SCLP | Update on patient recruitment in clinical trial | RNS | -7.69% |
| 07:00 12-Dec-2012 | SCLP | Directorate Change | RNS | -12.49% |
| 07:00 12-Dec-2012 | SCLP | SCIB1 Trial-Higher Dose Allowed in Phase 1/2 Trial | RNS | -12.49% |
| 07:00 06-Dec-2012 | SCLP | Update on SCIB1 Phase 1/2 clinical trial | RNS | -2.10% |
| 09:30 03-Dec-2012 | SCLP | Holding(s) in Company | RNS | +6.13% |
| 16:02 07-Nov-2012 | SCLP | Result of AGM | RNS | +8.03% |
| 07:00 12-Oct-2012 | SCLP | Final Results | RNS | -12.38% |
| 10:43 08-Oct-2012 | SCLP | Holding(s) in Company | RNS | +14.96% |
| 10:43 08-Oct-2012 | SCLP | Holding(s) in Company | RNS | +14.96% |
| 10:31 08-Oct-2012 | SCLP | Notice of Results and Share Price Movement | RNS | +14.96% |
| 15:30 03-Oct-2012 | SCLP | Change of Advisers | RNS | +32.73% |
| 11:10 10-Sep-2012 | SCLP | Holding(s) in Company | RNS | +1.55% |
| 17:39 03-Sep-2012 | SCLP | Holding(s) in Company | RNS | +2.86% |
| 07:00 23-Aug-2012 | SCLP | Holding(s) in Company | RNS | -5.08% |
| 16:03 20-Aug-2012 | SCLP | Holding(s) in Company | RNS | +11.37% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds